Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

How Vertex Pharmaceuticals Wowed With Its Q2 Results

TheMotleyFool

0 0

How Vertex Pharmaceuticals Wowed With Its Q2 ResultsPhoto, wide shot, wide-angle lens, Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png

Vertex Pharmaceuticals (NASDAQ: VRTX) has been on a roll so far in 2020. The big biotech delivered strong growth in the first quarter. It received a positive opinion from the European Medical Agency's Committee for Medicinal Products for Human Use regarding the potential approval of cystic fibrosis (CF) drug Kaftrio. And its shares have soared nearly 29% year to date.

The company announced its second-quarter results after the market closed on Thursday. It looks like Vertex's good times will keep rolling. Here are the highlights from the biotech's Q2 update.

Image Source: Getty Images.

Source Fool.com

Like: 0

VRTX

Teilen